Discovery of α-Ketoamide inhibitors of SARS-CoV-2 main protease derived from quaternized P1 groups

被引：2
|
作者：
Huang, Qiao [1 ]
Quan, Baoxue [2 ,3 ]
Chen, Yan [2 ,3 ]
Zhao, Xiu [2 ,3 ]
Zhou, Yanmei [2 ,3 ]
Huang, Chong [2 ,3 ]
Qiao, Jingxin [2 ,3 ]
Wang, Yifei [2 ,3 ]
Li, Yueyue [2 ,3 ]
Yang, Shengyong [2 ,3 ,4 ]
Lei, Jian [2 ,3 ,5 ]
Li, Linli [1 ]
机构：
[1] Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Minist Educ, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Canc Ctr, Dept Biotherapy, Chengdu 610041, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China
[4] Frontier Med Ctr, Tianfu Jincheng Lab, Chengdu 610212, Sichuan, Peoples R China
[5] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Chengdu 610041, Sichuan, Peoples R China
来源：
BIOORGANIC CHEMISTRY | 2024年 / 143卷
基金：
中国国家自然科学基金;
关键词：
SARS-CoV-2; Main protease; Covalent inhibitor; Protein structure; POTENT;
D O I：
10.1016/j.bioorg.2023.107001
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Although the SARS-CoV-2 pandemic has ended, multiple sporadic cases still exist, posing a request for more antivirals. The main protease (Mpro) of SARS-CoV-2, a key enzyme for viral replication, is an attractive target for drug development. Here, we report the discovery of a new potent alpha-ketoamide-containing Mpro inhibitor, N-((R)1-cyclohexyl-2-(((R)-3-methoxy-1-oxo-1-((1-(2-oxo-2-((thiazol-2-ylmethyl)amino)acetyl)cyclobutyl)amino) propan-2-yl)amino)-2-oxoethyl)-4,4-difluorocyclohexane-1-carboxamide (20j). This compound presented promising enzymatic inhibitory activity against SARS-CoV-2 Mpro with an IC50 value of 19.0 nM, and an excellent antiviral activity in cell-based assay with an EC50 value of 138.1 nM. This novel covalent inhibitor may be used as a lead compound for subsequent drug discovery against SARS-CoV-2.
引用
收藏
页数：12
相关论文
共 50 条
  • [1] Potent ketoamide inhibitors of HCV NS3 protease derived from quaternized P1 groups
    Venkatraman, Srikanth
    Velazquez, Francisco
    Wu, Wanli
    Blackman, Melissa
    Madison, Vincent
    Njoroge, F. George
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (07) : 2151 - 2155
  • [2] Discovery of novel inhibitors of SARS-CoV-2 main protease
    Zheng, Lei
    Chen, Yanmei
    Bao, Jingxiao
    He, Liping
    Dong, Suzhen
    Qi, Yifei
    Zhang, John Z. H.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (23): : 12526 - 12534
  • [3] Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors
    Huff, Sarah
    Kummetha, Indrasena Reddy
    Tiwari, Shashi Kant
    Huante, Matthew B.
    Clark, Alex E.
    Wang, Shaobo
    Bray, William
    Smith, Davey
    Carlin, Aaron F.
    Endsley, Mark
    Rana, Tariq M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (04) : 2866 - 2879
  • [4] Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
    Zhang, Linlin
    Lin, Daizong
    Sun, Xinyuanyuan
    Curth, Ute
    Drosten, Christian
    Sauerhering, Lucie
    Becker, Stephan
    Rox, Katharina
    Hilgenfeld, Rolf
    SCIENCE, 2020, 368 (6489) : 409 - +
  • [5] Discovery of 2-thiobenzimidazoles as noncovalent inhibitors of SARS-CoV-2 main protease
    Deodato, Davide
    Asad, Nadeem
    Dore, Timothy M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 72
  • [6] In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database
    Muhtar, Eldar
    Wang, Mengyang
    Zhu, Haimei
    FUTURE VIROLOGY, 2021, 16 (08) : 507 - 518
  • [7] Allosteric inhibitors of the main protease of SARS-CoV-2
    Samrat, Subodh Kumar
    Xu, Jimin
    Xie, Xuping
    Gianti, Eleonora
    Chen, Haiying
    Zou, Jing
    Pattis, Jason G.
    Elokely, Khaled
    Lee, Hyun
    Li, Zhong
    Klein, Michael L.
    Shi, Pei-Yong
    Zhou, Jia
    Li, Hongmin
    ANTIVIRAL RESEARCH, 2022, 205
  • [8] Developing inhibitors of the SARS-CoV-2 main protease
    Seitz, Christian
    Markota, Vedran
    Sztain-Pedone, Terra
    Esler, Morgan
    Moghadasi, Arad
    Kennelly, Samantha
    Demir, Ozlem
    Aihara, Hideki
    Harki, Daniel A.
    Harris, Reuben
    McCammon, J. Andrew
    Amaro, Rommie E.
    BIOPHYSICAL JOURNAL, 2022, 121 (03) : 192A - 192A
  • [9] Potential SARS-CoV-2 main protease inhibitors
    Banerjee, Riddhidev
    Perera, Lalith
    Tillekeratne, L. M. Viranga
    DRUG DISCOVERY TODAY, 2021, 26 (03) : 804 - 816
  • [10] On the origins of SARS-CoV-2 main protease inhibitors
    Janin, Yves L.
    RSC MEDICINAL CHEMISTRY, 2024, 15 (01): : 81 - 118
12345